These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 22162223

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N, Parc C, Scavennec R, Dhôte R, Brézin AP, Guillevin L.
    Presse Med; 2005 Jul 23; 34(13):916-8. PubMed ID: 16142147
    [Abstract] [Full Text] [Related]

  • 43. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
    Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D, Ackermann F, Pérard L, Hot A, Maurier F, Mausservey C, Bernard F, Noel N, Alric L, Mirault T, Cohen F, Boussouar S, Resche-Rigon M, Cacoub P, Saadoun D.
    Clin Immunol; 2018 Dec 23; 197():54-59. PubMed ID: 30125675
    [Abstract] [Full Text] [Related]

  • 44. Induction of ocular Behçet's disease remission after short-term treatment with infliximab: a case series of 11 patients with a follow-up from 4 to 16 years.
    Sfikakis PP, Arida A, Ladas DS, Markomichelakis N.
    Clin Exp Rheumatol; 2019 Dec 23; 37 Suppl 121(6):137-141. PubMed ID: 31856941
    [Abstract] [Full Text] [Related]

  • 45. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M.
    Arthritis Rheum; 1998 Sep 23; 41(9):1552-63. PubMed ID: 9751087
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation.
    Li EK, Griffith JF, Lee VW, Wang YX, Li TK, Lee KK, Tam LS.
    Rheumatology (Oxford); 2008 Sep 23; 47(9):1358-63. PubMed ID: 18573802
    [Abstract] [Full Text] [Related]

  • 49. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
    Pavelka K, Jarosová K, Suchý D, Senolt L, Chroust K, Dusek L, Vencovský J.
    Ann Rheum Dis; 2009 Aug 23; 68(8):1285-9. PubMed ID: 19351624
    [Abstract] [Full Text] [Related]

  • 50. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P, Nzeusseu Toukap A, Lauwerys BR, Manicourt DH, Verschueren P, Westhovens R, Devogelaer JP, Houssiau FA.
    Ann Rheum Dis; 2004 Sep 23; 63(9):1069-74. PubMed ID: 15308515
    [Abstract] [Full Text] [Related]

  • 51. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J, Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.
    Arthritis Rheum; 2005 Feb 23; 52(2):582-91. PubMed ID: 15692973
    [Abstract] [Full Text] [Related]

  • 52. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
    Atzeni F, Leccese P, D'Angelo S, Sarzi-Puttini P, Olivieri I.
    Clin Exp Rheumatol; 2010 Feb 23; 28(4 Suppl 60):S94. PubMed ID: 20868581
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behçet Network.
    J Autoimmun; 2015 Aug 23; 62():67-74. PubMed ID: 26162757
    [Abstract] [Full Text] [Related]

  • 57. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M, Reihl M, Habek M, Vukojević N, Anić B.
    Rheumatol Int; 2018 Jul 23; 38(7):1301-1306. PubMed ID: 29777341
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
    Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L.
    Clin Exp Rheumatol; 2011 Jul 23; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.